VivoSeq
Other

Intensive Care

0

Pipeline Programs↗

11

Active Trials↗

1

Companies Involved↗

Intensive Care is an early-stage landscape with 0 programs across 1 company. The most active players are POLYSAN Scientific & Technological Pharmaceutical Company.

Intelligence

Pipeline Metrics

Competitive Density

28/100

Pipeline Velocity

22/100

Mech. Concentration

N/A

Completion Rate

100/100

Attrition Rate

0/100

Competition

Competitive Landscape

Bubble size = clinical trials

Approved
Phase 3
Phase 2
Phase 1
Preclinical

Key Players

Top Companies Companies ranked by the number of pipeline programs they run for this disease.

P

POLYSAN Scientific & Technological Pharmaceutical Company

0 programs

Preclinical

Pipeline

Programs by Phase

No pipeline programs currently tracked for this disease.

Analysis

Trial Status

36

clinical trials

Completed20 · 56%
Recruiting6 · 17%
Unknown status5 · 14%
Not yet recruiting3 · 8%
Active, not recruiting2 · 6%

Clinical Trials

Trial Activity

36 trials

The Role of Furosemide Stress Test in the Intensive Care Clinic
Recruiting·GGulhane Training and Research Hospital·N/A·NCT06765031·140 enrolled
Morphine Clearance and Glomerular Filtration in Sickle Cell Patients in Crisis in Intensive Care
Recruiting·UUniversity Hospital, Tours·N/A·NCT07246265·100 enrolled
The Intensive Care Platform Trial
Recruiting·—·Phase 4·NCT06667999·10,000 enrolled
Weaning Protocol for High-flow Nasal Oxygen Therapy in Intensive Care
Recruiting·UUniversity Hospital, Tours·N/A·NCT06104956·370 enrolled
Impact of the Characteristics of Acute Renal Failure in Intensive Care on the Long-term Renal Prognosis: Prospective Multicenter Cohort Study
Recruiting·UUniversity Hospital, Clermont-Ferrand·N/A·NCT05247502·860 enrolled
IMPACT - Intensive Care Outcome Prediction Using Admission Carbohydrate-deficient Transferrin A Prospective Single-center Cohort Study
Recruiting·MMedical University of Vienna·N/A·NCT07632716·800 enrolled
ABC - A Post Intensive Care Anaemia Management Trial
Active, not recruiting·UUniversity of Edinburgh·N/A·NCT04591574·346 enrolled
Neopterin on Admission to the ICU: an Immunological Biomarker That Could Help Admission Decisions by Identifying Elderly Patients (≥80 Years) Able to Survive an ICU Stay Without Disability
Active, not recruiting·AAssistance Publique - Hôpitaux de Paris·N/A·NCT05233267·313 enrolled
Efficacy of Early Argipressin in the Management of Intensive Care Patients With Norepinephrine-refractory Vasoplegic Shock
Not yet recruiting·—·Phase 3·NCT07063680·390 enrolled
Automated System for Monitoring Urine Output in Intensive Care Patients
Not yet recruiting·MMeir Medical Center·N/A·NCT05232045·1,800 enrolled
Early Identification of Post-ICU Cognitive Impairment Using Eye-Tracking Technology: A Prospective Observational Study
Not yet recruiting·SShanghai Zhongshan Hospital·N/A·NCT07676864·73 enrolled
Pharmacokinetics of Enoxaparin in Intensive Care Patients
Completed·TTampere University Hospital·Phase 4·NCT02095509·39 enrolled
Balanced Solution Versus Saline in Intensive Care Study
Completed·HHospital do Coracao·Phase 3·NCT02875873·11,075 enrolled
Pediatric Intensive Care Ulcer Prophylaxis Pilot Trial
Completed·MMcMaster University·Phase 3·NCT02929563·116 enrolled
Monitoring Mitophagy In Myeloid Cells Upon Intensive Care
Completed·—·N/A·NCT05040503·205 enrolled
Page 1 of 3

Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)